UNIVERSAL HEALTH SERVICES-B (UHS) Stock Fundamental Analysis
USA - New York Stock Exchange - NYSE:UHS - US9139031002 - Common Stock
199.68 USD
-2.13 (-1.06%)
We assign a fundamental rating of 6 out of 10 to UHS. UHS was compared to 100 industry peers in the Health Care Providers & Services industry. While UHS has a great profitability rating, there are some minor concerns on its financial health. UHS may be a bit undervalued, certainly considering the very reasonable score on growth These ratings would make UHS suitable for value investing!
1. Profitability
1.1 Basic Checks
- UHS had positive earnings in the past year.
- UHS had a positive operating cash flow in the past year.
- In the past 5 years UHS has always been profitable.
- In the past 5 years UHS always reported a positive cash flow from operatings.
1.2 Ratios
- With an excellent Return On Assets value of 8.96%, UHS belongs to the best of the industry, outperforming 92.00% of the companies in the same industry.
- The Return On Equity of UHS (19.18%) is better than 87.00% of its industry peers.
- The Return On Invested Capital of UHS (12.33%) is better than 87.00% of its industry peers.
- UHS had an Average Return On Invested Capital over the past 3 years of 8.28%. This is in line with the industry average of 9.19%.
- The last Return On Invested Capital (12.33%) for UHS is above the 3 year average (8.28%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 8.96% | ||
| ROE | 19.18% | ||
| ROIC | 12.33% |
ROA(3y)6.01%
ROA(5y)6.51%
ROE(3y)13.4%
ROE(5y)14.27%
ROIC(3y)8.28%
ROIC(5y)8.76%
1.3 Margins
- The Profit Margin of UHS (8.09%) is better than 89.00% of its industry peers.
- UHS's Profit Margin has been stable in the last couple of years.
- UHS has a Operating Margin of 11.47%. This is amongst the best in the industry. UHS outperforms 81.00% of its industry peers.
- UHS's Operating Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 11.47% | ||
| PM (TTM) | 8.09% | ||
| GM | N/A |
OM growth 3Y-0.49%
OM growth 5Y-0.12%
PM growth 3Y-2.68%
PM growth 5Y0.2%
GM growth 3YN/A
GM growth 5YN/A
2. Health
2.1 Basic Checks
- With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), UHS is creating some value.
- UHS has less shares outstanding than it did 1 year ago.
- The number of shares outstanding for UHS has been reduced compared to 5 years ago.
- The debt/assets ratio for UHS has been reduced compared to a year ago.
2.2 Solvency
- An Altman-Z score of 3.11 indicates that UHS is not in any danger for bankruptcy at the moment.
- Looking at the Altman-Z score, with a value of 3.11, UHS is in the better half of the industry, outperforming 66.00% of the companies in the same industry.
- UHS has a debt to FCF ratio of 4.84. This is a neutral value as UHS would need 4.84 years to pay back of all of its debts.
- UHS's Debt to FCF ratio of 4.84 is fine compared to the rest of the industry. UHS outperforms 66.00% of its industry peers.
- UHS has a Debt/Equity ratio of 0.55. This is a neutral value indicating UHS is somewhat dependend on debt financing.
- UHS's Debt to Equity ratio of 0.55 is fine compared to the rest of the industry. UHS outperforms 61.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.55 | ||
| Debt/FCF | 4.84 | ||
| Altman-Z | 3.11 |
ROIC/WACC1.49
WACC8.27%
2.3 Liquidity
- UHS has a Current Ratio of 1.03. This is a normal value and indicates that UHS is financially healthy and should not expect problems in meeting its short term obligations.
- UHS has a worse Current ratio (1.03) than 71.00% of its industry peers.
- A Quick Ratio of 0.96 indicates that UHS may have some problems paying its short term obligations.
- The Quick ratio of UHS (0.96) is worse than 68.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.03 | ||
| Quick Ratio | 0.96 |
3. Growth
3.1 Past
- UHS shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 40.07%, which is quite impressive.
- Measured over the past years, UHS shows a quite strong growth in Earnings Per Share. The EPS has been growing by 10.74% on average per year.
- UHS shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 10.21%.
- Measured over the past years, UHS shows a small growth in Revenue. The Revenue has been growing by 6.82% on average per year.
EPS 1Y (TTM)40.07%
EPS 3Y12.08%
EPS 5Y10.74%
EPS Q2Q%53.37%
Revenue 1Y (TTM)10.21%
Revenue growth 3Y7.78%
Revenue growth 5Y6.82%
Sales Q2Q%13.43%
3.2 Future
- UHS is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 13.53% yearly.
- UHS is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 4.90% yearly.
EPS Next Y32.21%
EPS Next 2Y19.65%
EPS Next 3Y16.81%
EPS Next 5Y13.53%
Revenue Next Year10.55%
Revenue Next 2Y7.74%
Revenue Next 3Y6.89%
Revenue Next 5Y4.9%
3.3 Evolution
- The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
- When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
- A Price/Earnings ratio of 9.60 indicates a reasonable valuation of UHS.
- Based on the Price/Earnings ratio, UHS is valued cheaper than 93.00% of the companies in the same industry.
- When comparing the Price/Earnings ratio of UHS to the average of the S&P500 Index (27.30), we can say UHS is valued rather cheaply.
- Based on the Price/Forward Earnings ratio of 8.38, the valuation of UHS can be described as reasonable.
- Based on the Price/Forward Earnings ratio, UHS is valued cheaply inside the industry as 95.00% of the companies are valued more expensively.
- UHS's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 24.04.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 9.6 | ||
| Fwd PE | 8.38 |
4.2 Price Multiples
- 85.00% of the companies in the same industry are more expensive than UHS, based on the Enterprise Value to EBITDA ratio.
- Based on the Price/Free Cash Flow ratio, UHS is valued a bit cheaper than 79.00% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 12.88 | ||
| EV/EBITDA | 6.74 |
4.3 Compensation for Growth
- UHS's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
- The decent profitability rating of UHS may justify a higher PE ratio.
- A more expensive valuation may be justified as UHS's earnings are expected to grow with 16.81% in the coming years.
PEG (NY)0.3
PEG (5Y)0.89
EPS Next 2Y19.65%
EPS Next 3Y16.81%
5. Dividend
5.1 Amount
- With a yearly dividend of 0.38%, UHS is not a good candidate for dividend investing.
- Compared to an average industry Dividend Yield of 0.59, UHS pays a bit more dividend than its industry peers.
- With a Dividend Yield of 0.38, UHS pays less dividend than the S&P500 average, which is at 1.92.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.38% |
5.2 History
- On average, the dividend of UHS grows each year by 6.27%, which is quite nice.
- UHS has paid a dividend for at least 10 years, which is a reliable track record.
- UHS has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)6.27%
Div Incr Years0
Div Non Decr Years4
5.3 Sustainability
- 3.78% of the earnings are spent on dividend by UHS. This is a low number and sustainable payout ratio.
- The dividend of UHS is growing, but earnings are growing more, so the dividend growth is sustainable.
DP3.78%
EPS Next 2Y19.65%
EPS Next 3Y16.81%
NYSE:UHS (1/14/2026, 10:41:53 AM)
199.68
-2.13 (-1.06%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)10-27 2025-10-27/amc
Earnings (Next)02-24 2026-02-24/amc
Inst Owners98.09%
Inst Owner Change0.19%
Ins Owners5.68%
Ins Owner Change16.62%
Market Cap12.48B
Revenue(TTM)16.99B
Net Income(TTM)1.38B
Analysts71.54
Price Target254.83 (27.62%)
Short Float %3.96%
Short Ratio2.99
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.38% |
Yearly Dividend0.81
Dividend Growth(5Y)6.27%
DP3.78%
Div Incr Years0
Div Non Decr Years4
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)12.07%
Min EPS beat(2)7.62%
Max EPS beat(2)16.52%
EPS beat(4)4
Avg EPS beat(4)12.73%
Min EPS beat(4)7.62%
Max EPS beat(4)16.65%
EPS beat(8)8
Avg EPS beat(8)13.14%
EPS beat(12)12
Avg EPS beat(12)10.1%
EPS beat(16)14
Avg EPS beat(16)6.62%
Revenue beat(2)2
Avg Revenue beat(2)1.31%
Min Revenue beat(2)0.18%
Max Revenue beat(2)2.44%
Revenue beat(4)3
Avg Revenue beat(4)0.48%
Min Revenue beat(4)-2.29%
Max Revenue beat(4)2.44%
Revenue beat(8)7
Avg Revenue beat(8)0.45%
Revenue beat(12)9
Avg Revenue beat(12)0.29%
Revenue beat(16)13
Avg Revenue beat(16)0.58%
PT rev (1m)0.81%
PT rev (3m)14.81%
EPS NQ rev (1m)0.01%
EPS NQ rev (3m)4.14%
EPS NY rev (1m)0.46%
EPS NY rev (3m)6.09%
Revenue NQ rev (1m)-0.02%
Revenue NQ rev (3m)0.55%
Revenue NY rev (1m)-0.01%
Revenue NY rev (3m)1.14%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 9.6 | ||
| Fwd PE | 8.38 | ||
| P/S | 0.73 | ||
| P/FCF | 12.88 | ||
| P/OCF | 6.4 | ||
| P/B | 1.74 | ||
| P/tB | 3.92 | ||
| EV/EBITDA | 6.74 |
EPS(TTM)20.8
EY10.42%
EPS(NY)23.82
Fwd EY11.93%
FCF(TTM)15.5
FCFY7.76%
OCF(TTM)31.18
OCFY15.62%
SpS271.97
BVpS114.75
TBVpS50.9
PEG (NY)0.3
PEG (5Y)0.89
Graham Number231.74
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 8.96% | ||
| ROE | 19.18% | ||
| ROCE | 16% | ||
| ROIC | 12.33% | ||
| ROICexc | 12.44% | ||
| ROICexgc | 18.59% | ||
| OM | 11.47% | ||
| PM (TTM) | 8.09% | ||
| GM | N/A | ||
| FCFM | 5.7% |
ROA(3y)6.01%
ROA(5y)6.51%
ROE(3y)13.4%
ROE(5y)14.27%
ROIC(3y)8.28%
ROIC(5y)8.76%
ROICexc(3y)8.36%
ROICexc(5y)9.07%
ROICexgc(3y)12.5%
ROICexgc(5y)14.04%
ROCE(3y)10.74%
ROCE(5y)11.37%
ROICexgc growth 3Y1.9%
ROICexgc growth 5Y0.81%
ROICexc growth 3Y3.79%
ROICexc growth 5Y2.74%
OM growth 3Y-0.49%
OM growth 5Y-0.12%
PM growth 3Y-2.68%
PM growth 5Y0.2%
GM growth 3YN/A
GM growth 5YN/A
F-Score8
Asset Turnover1.11
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.55 | ||
| Debt/FCF | 4.84 | ||
| Debt/EBITDA | 1.55 | ||
| Cap/Depr | 162.72% | ||
| Cap/Sales | 5.77% | ||
| Interest Coverage | 15.36 | ||
| Cash Conversion | 76.35% | ||
| Profit Quality | 70.41% | ||
| Current Ratio | 1.03 | ||
| Quick Ratio | 0.96 | ||
| Altman-Z | 3.11 |
F-Score8
WACC8.27%
ROIC/WACC1.49
Cap/Depr(3y)139.45%
Cap/Depr(5y)144.53%
Cap/Sales(3y)5.55%
Cap/Sales(5y)5.95%
Profit Quality(3y)70.11%
Profit Quality(5y)77.19%
High Growth Momentum
Growth
EPS 1Y (TTM)40.07%
EPS 3Y12.08%
EPS 5Y10.74%
EPS Q2Q%53.37%
EPS Next Y32.21%
EPS Next 2Y19.65%
EPS Next 3Y16.81%
EPS Next 5Y13.53%
Revenue 1Y (TTM)10.21%
Revenue growth 3Y7.78%
Revenue growth 5Y6.82%
Sales Q2Q%13.43%
Revenue Next Year10.55%
Revenue Next 2Y7.74%
Revenue Next 3Y6.89%
Revenue Next 5Y4.9%
EBIT growth 1Y26.53%
EBIT growth 3Y7.25%
EBIT growth 5Y6.7%
EBIT Next Year60.74%
EBIT Next 3Y20.8%
EBIT Next 5YN/A
FCF growth 1Y135.27%
FCF growth 3Y242.18%
FCF growth 5Y7.48%
OCF growth 1Y75.09%
OCF growth 3Y32.75%
OCF growth 5Y7.52%
UNIVERSAL HEALTH SERVICES-B / UHS FAQ
What is the fundamental rating for UHS stock?
ChartMill assigns a fundamental rating of 6 / 10 to UHS.
Can you provide the valuation status for UNIVERSAL HEALTH SERVICES-B?
ChartMill assigns a valuation rating of 8 / 10 to UNIVERSAL HEALTH SERVICES-B (UHS). This can be considered as Undervalued.
What is the profitability of UHS stock?
UNIVERSAL HEALTH SERVICES-B (UHS) has a profitability rating of 7 / 10.
What is the financial health of UNIVERSAL HEALTH SERVICES-B (UHS) stock?
The financial health rating of UNIVERSAL HEALTH SERVICES-B (UHS) is 5 / 10.
How sustainable is the dividend of UNIVERSAL HEALTH SERVICES-B (UHS) stock?
The dividend rating of UNIVERSAL HEALTH SERVICES-B (UHS) is 5 / 10 and the dividend payout ratio is 3.78%.